Feeds:
Posts
Comments

New Technique Successfully Dissolves Blood Clots in the Brain and Lowers Risk of Brain Damage After Stroke
CT-guided catheters carry clot-busting drug to shrink clots, Johns Hopkins-led study shows.

http://www.hopkinsmedicine.org/news/media/releases/new_technique_successfully_dissolves_blood_clots_in_the_brain_and_lowers_risk_of_brain_damage_after_stroke

Johns Hopkins neurologists report success with a new means of getting rid of potentially lethal blood clots in the brain safely without cutting through easily damaged brain tissue or removing large pieces of skull. The minimally invasive treatment, they report, increased the number of patients with intracerebral hemorrhage (ICH) who could function independently by 10 to 15 percent six months following the procedure.

The new study was coordinated by Johns Hopkins and the surgical review centers at the University of Cincinnati and the University of Chicago. All 93 patients were diagnosed with ICH, a particularly lethal or debilitating form of stroke long considered surgically untreatable under most circumstances.

“The last untreatable form of stroke may well have a treatment,” says study leader Daniel F. Hanley, M.D., a professor of neurology at the Johns Hopkins University School of Medicine. “If a larger study proves our findings correct, we may substantially reduce the burden of strokes for patients and their families by increasing the number of people who can be independent again after suffering a stroke.”

ICH is a bleed in the brain that causes a clot to form, often caused by uncontrolled high blood pressure. The clot builds up pressure and leaches inflammatory chemicals that can cause irreversible brain damage, often leading to death or extreme disability. The standard of care for ICH patients is general supportive care, usually in an ICU; only 10 percent undergo the more invasive and risky craniotomy surgery, which involves removing a portion of the skull and making incisions through healthy brain tissue to reach and remove the clot. Roughly 50 percent of people who suffer an intracerebral hemorrhage die from it. For more information:

http://www.hopkinsmedicine.org/profiles/results/directory/profile/0001943/daniel-hanley?firstLetter=H

http://www.hopkinsmedicine.org/neurology_neurosurger

Continue Reading »

In October 2000, the truth started to emerge with the publication of a seminal study titled, “Aerotoxic Syndrome: Adverse health effects following exposure to jet oil mist during commercial flights,” authored by Dr Harry Hoffman, Professor Chris Winder and Jean Christophe Balouet, Ph.D . In the study, the researchers introduce aerotoxic syndrome as a newly identified occupational health condition. They focused on 10 case reports of airline crew who experienced a so-called “fume event,” and subsequent health problems.(see below link)

http://www.greenmedinfo.com/blog/asbestos-sky-aviation-industry-s-darkest-coverup

http://aerotoxic.org/information/reports-and-evidence/aerotoxic-sydrome-adverse-health-effects-following-exposure-jet-oil-mist-commercial-flights/

What are the symptoms of aerotoxicosis

“Blurred or tunnel vision, disorientation, memory impairment, shaking and tremors, nausea/vomiting, paresthesias, loss of balance and vertigo, seizures, loss of consciousness, headache, lightheadedness, dizziness, confusion and feeling intoxicated, breathing difficulties (shortness of breath, tightness in chest, respiratory failure), increased heart rate and palpitations, nystagmus, irritation (eyes, nose and upper airways).”

Symptoms from long term low level exposure or residual symptoms from short term exposures include: “memory impairment, forgetfulness, lack of coordination, nausea/vomiting, diarrhoea, respiratory problems, chest pain, severe headaches, dizziness and feeling intoxicated, weakness and fatigue (leading to chronic fatigue), exhaustion, increased heart rate and palpitations, numbness (fingers, lips, limbs), hot flashes, joint pain, muscle weakness and pain, salivation, irritation (eyes, nose and upper airways), skin itching and rashes, skin blisters (on uncovered body parts), signs of immunosupression, hair loss, chemical sensitivity leading to acquired or multiple chemical sensitivity.”

Clearly, if these symptoms are indeed caused by exposure to “bleed air,” or exaggerated ‘fume events,’ these chemicals have the ability to cause profound damage to the human body, particularly the nervous and immune systems.

http://www.greenmedinfo.com/blog/asbestos-sky-aviation-industry-s-darkest-coverup

http://aerotoxic.org/information/reports-and-evidence/aerotoxic-sydrome-adverse-health-effects-following-exposure-jet-oil-mist-commercial-flights/

Cannabinoids and gliomas. Velasco G, Carracedo A, Blázquez C, Lorente M, Aguado T, Haro A, Sánchez C, Galve-Roperh I, Guzmán M. https://www.ncbi.nlm.nih.gov/pubmed/17952650

Cannabinoids, the active components of Cannabis sativa L., act in the body by mimicking endogenous substances–the endocannabinoids–that activate specific cell surface receptors. Cannabinoids exert various palliative effects in cancer patients. In addition, cannabinoids inhibit the growth of different types of tumor cells, including glioma cells, in laboratory animals.

They do so by modulating key cell signaling pathways, mostly the endoplasmic reticulum stress response, thereby inducing antitumoral actions such as the apoptotic death of tumor cells and the inhibition of tumor angiogenesis. Of interest, cannabinoids seem to be selective antitumoral compounds, as they kill glioma cells, but not their non-transformed astroglial counterparts.

On the basis of these preclinical findings, a pilot clinical study of Delta(9)-tetrahydrocannabinol (THC) in patients with recurrent glioblastoma multiforme has been recently run. The good safety profile of THC, together with its possible growth-inhibiting action on tumor cells, justifies the setting up of future trials aimed at evaluating the potential antitumoral activity of cannabinoids.

Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells.

https://www.ncbi.nlm.nih.gov/pubmed/27918106

Rajan TS, Giacoppo S, Scionti D Diomede F, Grassi G, Pollastro F, Piattelli A, Bramanti P Mazzon E, Trubiani O

In the last years, mesenchymal stromal cells (MSCs) from oral tissues have received considerable interest in regenerative medicine since they can be obtained with minimal invasive procedure and exhibit immunomodulatory properties. “From our results we hypothesize that human gingiva-derived MSCs conditioned with CBD could represent a valid method for improving the hGMSCs phenotype and thus might be a potential therapeutic tool in the treatment of neurodegenerative diseases.”

This study was aimed to investigate whether in vitro pre-treatment of MSCs obtained from human gingiva (hGMSCs) with Cannabidiol (CBD), a cannabinoid component produced by the plant Cannabis sativa, may promote human gingiva derived MSCs to differentiate towards neuronal precursor cells.

Specifically, we have treated the hGMSCs with CBD (5µM) for 24 h in order to evaluate theexpression of genes involved in cannabidiol signaling, cell proliferation, self-renewal and multipotency, and neural progenitor cells differentiation.

Next generation sequencing (NGS) demonstrated that CBD activates genes associated with G protein coupled receptor signaling in hGMSCs. Genes involved in DNA replication, cell cycle, proliferation and apoptosis were regulated. Moreover, genes associated with the biological process of neuronal progenitor cells (NCPs) proliferation, neuron differentiation, neurogenesis and nervous system development were significantly modulated.

From our results we hypothesize that human gingiva-derived MSCs conditioned with CBD could represent a valid method for improving the hGMSCs phenotype and thus might be a potential therapeutic tool in the treatment of neurodegenerative diseases.

https://www.ncbi.nlm.nih.gov/pubmed/27918106

Fertilizer helps crops grow better, but nutrient runoff can lead to serious environmental problems. Ed Rosenthal, founder of Sarasota, Florida-based Florikan, had an idea to control the nutrient release to avoid runoff and maximize the benefit to the plant. He perfected the formula thanks to 40 hours of NASA consulting, and the fertilizer is now sold around the world—and also used on the ISS for project Veggie.“NASA’s expertise helped us advance our development by years. We were happy to pay it back.” — Ed Rosenthal, Florikan

https://spinoff.nasa.gov/Spinoff2017/index.html

https://spinoff.nasa.gov/Spinoff2017/ee_2.html

http://www.spacefoundation.org/programs/space-certification/certified-partners/certified-companies/florikan-esa-llc

Continue Reading »

A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States ” the present study provides new epidemiological evidence supporting an association between increasing organic-Hg exposure from Thimerosal-containing childhood vaccines and the subsequent risk of an ASD diagnosis.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878266/
David A Geier, Brian S Hooker,  Janet K Kern, Paul G King, Lisa K Sykes, and Mark R Geier

Results In phase I, it was observed that there was a significantly increased risk ratio for the incidence of ASD reported following the Thimerosal-containing DTaP vaccine in comparison to the Thimerosal-free DTaP vaccine. In phase II, it was observed that cases diagnosed with an ASD were significantly more likely than controls to receive increased organic-Hg from Thimerosal-containing hepatitis B vaccine administered within the first, second, and sixth month of life.

Conclusions: Routine childhood vaccination is an important public health tool to reduce the morbidity and mortality associated with infectious diseases, but the present study provides new epidemiological evidence supporting an association between increasing organic-Hg exposure from Thimerosal-containing childhood vaccines and the subsequent risk of an ASD diagnosis.

Autism spectrum disorder (ASD) is defined by standardized criteria of qualitative impairments in social interaction, qualitative impairments in communication, and restricted and stereotyped patterns of behavior, interests, and activities. A significant number of children diagnosed with ASD suffer a loss of previously-acquired skills, which is suggestive of neurodegeneration or a type of progressive encephalopathy with an etiological pathogenic basis occurring after birth. To date, the etiology of ASD remains under debate, however, many studies suggest toxicity, especially from mercury (Hg), in individuals diagnosed with an ASD. The present study evaluated concerns about the toxic effects of organic-Hg exposure from Thimerosal (49.55% Hg by weight) in childhood vaccines by conducting a two-phased (hypothesis generating/hypothesis testing) study with documented exposure to varying levels of Thimerosal from vaccinations. Continue Reading »

Autism: a novel form of mercury poisoning

https://www.ncbi.nlm.nih.gov/pubmed/11339848/

Autism: a novel form of mercury poisoning. Bernard S1, Enayati A, Redwood L, Roger H, Binstock T.
Autism is a syndrome characterized by impairments in social relatedness and communication, repetitive behaviors, abnormal movements, and sensory dysfunction

A review of medical literature and US government data suggests that: (i) many cases of idiopathic autism are induced by early mercury exposure from thimerosal which is found in vaccines given to young children  Continue Reading »